Compounds > activins

activins and Carcinoma, Non-Small Cell Lung

activins has been researched along with Carcinoma, Non-Small Cell Lung in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's1 (25.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Chin, V; Daneshvar, D; Karikios, D; Lim, J; McCloy, R; Murphy, A; Nagrial, A; O'Toole, S; Steinmann, AM; Wong, S1
Ilonen, I; Järvinen, T; Koli, K; Lauri, H; Lemström, K; Myllärniemi, M; Ollila, H; Paajanen, J; Räsänen, J; Ritvos, O; Rouvinen, E; Sutinen, E1
Allison, DF; Bekiranov, S; Clift, SH; Hoang, SA; Holzknecht, CM; Jones, DR; Kumar, M; Mayo, MW; Moskaluk, CA; Szymura, SJ; Wamsley, JJ; Xu, X1
Feng, Y; Liu, Q; Ning, Y; Ou, X; Song, X; Wang, B; Wen, F; Yang, J; Zhang, X1

Other Studies

4 other study(ies) available for activins and Carcinoma, Non-Small Cell Lung

ArticleYear
Activin-A, Growth Differentiation Factor-11 and Transforming Growth Factor-β as predictive biomarkers for platinum chemotherapy in advanced non-small cell lung cancer.
    Cancer treatment and research communications, 2022, Volume: 32

    Topics: Activins; Adult; Biomarkers; Bone Morphogenetic Proteins; Carcinoma, Non-Small-Cell Lung; Growth Differentiation Factors; Humans; Lung Neoplasms; Organoplatinum Compounds; Platinum; Prospective Studies; Retrospective Studies; Transforming Growth Factor beta; Transforming Growth Factors

2022
Elevated Circulating Activin A Levels in Patients With Malignant Pleural Mesothelioma Are Related to Cancer Cachexia and Reduced Response to Platinum-based Chemotherapy.
    Clinical lung cancer, 2020, Volume: 21, Issue:3

    Topics: Activins; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cachexia; Carcinoma, Non-Small-Cell Lung; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Mesothelioma, Malignant; Middle Aged; Platinum; Pleural Neoplasms; Prognosis; Prospective Studies; Retrospective Studies; ROC Curve

2020
Activin upregulation by NF-κB is required to maintain mesenchymal features of cancer stem-like cells in non-small cell lung cancer.
    Cancer research, 2015, Jan-15, Volume: 75, Issue:2

    Topics: Activins; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Epithelial-Mesenchymal Transition; Humans; Inhibin-beta Subunits; Lung Neoplasms; Mesoderm; Neoplastic Stem Cells; NF-kappa B; RNA, Neoplasm; Spheroids, Cellular; Up-Regulation

2015
Involvement of ERK, Bcl-2 family and caspase 3 in recombinant human activin A-induced apoptosis in A549.
    Toxicology, 2009, Apr-28, Volume: 258, Issue:2-3

    Topics: Activins; Apoptosis; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Caspase 3; Cell Line, Tumor; Dose-Response Relationship, Drug; Extracellular Signal-Regulated MAP Kinases; Humans; In Situ Nick-End Labeling; Lung Neoplasms; Proto-Oncogene Proteins c-bcl-2; Recombinant Proteins

2009